Jhamb Manisha, Cavanaugh Kerri L, Bian Aihua, Chen Guanhua, Ikizler T Alp, Unruh Mark L, Abdel-Kader Khaled
Renal-Electrolyte Division, University of Pittsburgh, Pittsburgh, Pennsylvania;
Vanderbilt Center for Kidney Disease, Nashville, Tennessee; Division of Nephrology and Hypertension and.
Clin J Am Soc Nephrol. 2015 Nov 6;10(11):2013-22. doi: 10.2215/CJN.01640215. Epub 2015 Oct 22.
Electronic health record (EHR) patient portals allow individuals to access their medical information with the intent of patient empowerment. However, little is known about portal use in nephrology patients. We addressed this gap by characterizing adoption of an EHR portal, assessing secular trends, and examining the association of portal adoption and BP control (<140/90 mmHg).
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Patients seen between January 1, 2010, and December 31, 2012, at any of four university-affiliated nephrology offices who had at least one additional nephrology follow-up visit before June 30, 2013, were included. Sociodemographic characteristics, comorbidities, clinical measurements, and office visits were abstracted from the EHR. Neighborhood median household income was obtained from the American Community Survey 2012.
Of 2803 patients, 1098 (39%) accessed the portal. Over 87% of users reviewed laboratory results, 85% reviewed their medical information (e.g., medical history), 85% reviewed or altered appointments, 77% reviewed medications, 65% requested medication refills, and 31% requested medical advice from their renal provider. In adjusted models, older age, African-American race (odds ratio [OR], 0.50; 95% confidence interval [95% CI], 0.39 to 0.64), Medicaid status (OR, 0.53; 95% CI, 0.36 to 0.77), and lower neighborhood median household income were associated with not accessing the portal. Portal adoption increased over time (2011 versus 2010: OR, 1.38 [95% CI, 1.09 to 1.75]; 2012 versus 2010: OR, 1.95 [95% CI, 1.44 to 2.64]). Portal adoption was correlated with BP control in patients with a diagnosis of hypertension; however, in the fully adjusted model this was somewhat attenuated and no longer statistically significant (OR, 1.11; 95% CI, 0.99 to 1.24).
While portal adoption appears to be increasing, greater attention is needed to understand why vulnerable populations do not access it. Future research should examine barriers to the use of e-health technologies in underserved patients with CKD, interventions to address them, and their potential to improve outcomes.
电子健康记录(EHR)患者门户使个人能够访问自己的医疗信息,旨在增强患者权能。然而,对于肾脏病患者使用门户的情况知之甚少。我们通过描述电子健康记录门户的采用情况、评估长期趋势以及研究门户采用与血压控制(<140/90 mmHg)之间的关联来填补这一空白。
设计、地点、参与者及测量方法:纳入2010年1月1日至2012年12月31日期间在四家大学附属医院肾脏病科室就诊,且在2013年6月30日前至少有一次额外肾脏病随访就诊的患者。社会人口统计学特征、合并症、临床测量数据及门诊就诊信息均从电子健康记录中提取。邻里家庭收入中位数来自2012年美国社区调查。
2803例患者中,1098例(39%)访问了门户。超过87%的用户查看了实验室检查结果,85%查看了自己的医疗信息(如病史),85%查看或更改了预约,77%查看了用药情况,65%申请了药物续方,31%向肾脏科医生寻求医疗建议。在调整模型中,年龄较大、非裔美国人种族(优势比[OR],0.50;95%置信区间[95%CI],0.39至0.64)、医疗补助状态(OR,0.53;95%CI,0.36至0.77)以及邻里家庭收入中位数较低与未访问门户相关。随着时间推移,门户采用率有所增加(2011年与2010年相比:OR,1.38[95%CI,1.09至1.75];2012年与2010年相比:OR,1.95[95%CI,1.44至2.64])。在诊断为高血压的患者中,门户采用与血压控制相关;然而,在完全调整模型中,这种相关性有所减弱且不再具有统计学意义(OR,1.11;95%CI,0.99至1.24)。
虽然门户采用率似乎在上升,但需要更多关注来了解弱势群体不使用它的原因。未来研究应探讨在服务不足的慢性肾脏病患者中使用电子健康技术的障碍、解决这些障碍的干预措施以及它们改善结局的潜力。